February 12, 2026 21:18 ET | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus…
January 23, 2026 17:00 ET | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN FRANCISCO, Calif., Jan. 23, 2026 (GLOBE NEWSWIRE) --…
MCLEAN, Va., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”) refers to the press…
December 04, 2025 22:05 ET | Source: Symbotic Inc. WILMINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq:…
Extends cash runway through at least the first half of 2028Led by Vivo Capital, Janus Henderson Investors, Coastlands Capital, Columbia…
$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full…
November 21, 2025 16:30 ET | Source: Conavi Medical Corp. PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION…
November 18, 2025 16:51 ET | Source: Olema Oncology SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc.…
November 12, 2025 22:55 ET | Source: Annexon Biosciences BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”)…
October 26, 2025 19:15 ET | Source: Vivani Medical, Inc. ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical,…